Avantel's Q1 FY27 standalone revenue rose 35% to ₹70.12 crore. Net profit jumped 65% to ₹7.62 crore, driven by its communications segment. Board approved executive remuneration hike and reappointments.
Avantel Reports Strong Q1 FY27 Performance, Revenue Up 35%
Avantel Limited's standalone revenue surged by 35% to ₹70.12 crore for the quarter ended June 30, 2026, up from ₹51.84 crore in the same period last year. Standalone net profit saw a significant jump of 65%, reaching ₹7.62 crore compared to ₹4.62 crore.
Reader Takeaway: Robust core business growth driven by communications, while healthcare segment losses persist.
What just happened
The company announced its financial results for the first quarter of fiscal year 2027 (Q1 FY27). Key highlights include a substantial increase in both revenue and net profit on a standalone basis. The consolidated revenue also grew to ₹70.42 crore from ₹51.91 crore, with net profit rising to ₹5.39 crore from ₹3.23 crore.
Why this matters
This performance indicates strong operational momentum in Avantel's primary business. The growth in the Communications and Signal Processing segment, which contributes the majority of revenue and profit, is a positive sign for shareholders. However, the continued losses in the Healthcare segment are a drag on consolidated profitability.
The backstory
Avantel operates primarily in the Communications and Signal Processing segment, with a smaller, loss-making Healthcare division. The company has historically relied on government-related entities for a significant portion of its revenue, which it views as secure.
What changes now
In addition to the financial results, the Board of Directors approved a revised remuneration for Executive Director Mr. Abburi Siddhartha Sagar to ₹0.55 crore per annum and re-appointed him for a five-year term. Mr. Vyasabhattu Ramchander was re-appointed as Independent Director, and Mr. Peddi Bala Bhaskar Rao was appointed as Additional Director (Operations). The company also reconstituted key board committees.
Risks to watch
The primary risks highlighted are the persistent losses in the Healthcare segment and the company's significant reliance on a single government-controlled customer. While management is confident about receivables, this concentration remains a key operational factor.
Peer comparison
No peer comparison data was provided in the filing.
Context metrics (time-bound)
- Standalone Revenue (Q1 FY27): ₹70.12 crore (up 35% YoY)
- Standalone Net Profit (Q1 FY27): ₹7.62 crore (up 65% YoY)
- Consolidated Revenue (Q1 FY27): ₹70.42 crore (up 35.6% YoY)
- Consolidated Net Profit (Q1 FY27): ₹5.39 crore (up 66.9% YoY)
- Communications Segment PBT: ₹10.92 crore
- Healthcare Segment Loss: ₹2.22 crore
What to track next
Investors will be keen to watch the performance of the Healthcare segment and any strategic changes to address its losses. Monitoring the company's ability to diversify its customer base or maintain strong relations with its key government client will also be crucial.